{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T18:20:18Z","timestamp":1770834018010,"version":"3.50.1"},"reference-count":95,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["onlinecjc.ca","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Cardiology"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.cjca.2014.08.022","type":"journal-article","created":{"date-parts":[[2014,8,27]],"date-time":"2014-08-27T06:34:04Z","timestamp":1409121244000},"page":"1350-1360","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Regenerative Cell and Tissue-based Therapies for Pulmonary Arterial Hypertension"],"prefix":"10.1016","volume":"30","author":[{"given":"William S.","family":"Foster","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colin M.","family":"Suen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duncan J.","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjca.2014.08.022_bib1","doi-asserted-by":"crossref","first-page":"D34","DOI":"10.1016\/j.jacc.2013.10.029","article-title":"Updated clinical classification of pulmonary hypertension","volume":"62","author":"Simonneau","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2014.08.022_bib2","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1161\/CIRCULATIONAHA.108.847707","article-title":"Basic science of pulmonary arterial hypertension for clinicians: new concepts and experimental therapies","volume":"121","author":"Archer","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2014.08.022_bib3","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1056\/NEJMra035488","article-title":"Pulmonary arterial hypertension","volume":"351","author":"Farber","year":"2004","journal-title":"New Engl J Med"},{"key":"10.1016\/j.cjca.2014.08.022_bib4","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1161\/01.CIR.0000102381.57477.50","article-title":"Endothelial dysfunction in pulmonary hypertension","volume":"109","author":"Budhiraja","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2014.08.022_bib5","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/1465-9921-10-95","article-title":"Endothelial cells and pulmonary arterial hypertension: apoptosis, proliferation, interaction and transdifferentiation","volume":"10","author":"Sakao","year":"2009","journal-title":"Respir Res"},{"key":"10.1016\/j.cjca.2014.08.022_bib6","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1164\/ajrccm.159.6.9804054","article-title":"Prostacyclin synthase expression is decreased in lungs from patients with severe pulmonary hypertension","volume":"159","author":"Tuder","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.cjca.2014.08.022_bib7","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1056\/NEJM199507273330403","article-title":"Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension","volume":"333","author":"Giaid","year":"1995","journal-title":"New Engl J Med"},{"key":"10.1016\/j.cjca.2014.08.022_bib8","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1056\/NEJM199207093270202","article-title":"An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension","volume":"327","author":"Christman","year":"1992","journal-title":"New Engl J Med"},{"key":"10.1016\/j.cjca.2014.08.022_bib9","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1056\/NEJM199306173282402","article-title":"Expression of endothelin-1 in the lungs of patients with pulmonary hypertension","volume":"328","author":"Giaid","year":"1993","journal-title":"New Engl J Med"},{"key":"10.1016\/j.cjca.2014.08.022_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2009.12.006","article-title":"Role of apoptosis in pulmonary hypertension: from experimental models to clinical trials","volume":"126","author":"Jurasz","year":"2010","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.cjca.2014.08.022_bib11","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1161\/CIRCULATIONAHA.109.927681","article-title":"Formation of plexiform lesions in experimental severe pulmonary arterial hypertension","volume":"121","author":"Abe","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2014.08.022_bib12","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1161\/CIRCULATIONAHA.109.192230","volume":"119","author":"McLaughlin","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2014.08.022_bib13","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1183\/09031936.00072709","article-title":"Survival in pulmonary arterial hypertension: a reappraisal of the NIH risk stratification equation","volume":"35","author":"Thenappan","year":"2010","journal-title":"Eur Respir J"},{"key":"10.1016\/j.cjca.2014.08.022_bib14","doi-asserted-by":"crossref","first-page":"L1058","DOI":"10.1152\/ajplung.2001.281.5.L1058","article-title":"ET-1 stimulates pulmonary arterial smooth muscle cell proliferation via induction of reactive oxygen species","volume":"281","author":"Wedgwood","year":"2001","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.cjca.2014.08.022_bib15","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1002\/stem.37","article-title":"Deconstructing stem cell tumorigenicity: a roadmap to safe regenerative medicine","volume":"27","author":"Knoepfler","year":"2009","journal-title":"Stem Cells"},{"key":"10.1016\/j.cjca.2014.08.022_bib16","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1126\/science.275.5302.964","article-title":"Isolation of putative progenitor endothelial cells for angiogenesis","volume":"275","author":"Asahara","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.cjca.2014.08.022_bib17","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/386671a0","article-title":"Mechanisms of angiogenesis","volume":"386","author":"Risau","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.cjca.2014.08.022_bib18","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1182\/blood.V92.2.362","article-title":"Evidence for circulating bone marrow-derived endothelial cells","volume":"92","author":"Shi","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.cjca.2014.08.022_bib19","doi-asserted-by":"crossref","DOI":"10.1002\/9780470151808.sc02c01s6","article-title":"Isolation and characterization of endothelial progenitor cells from human blood","author":"Mead","year":"2008","journal-title":"Curr Protoc Stem Cell Biol"},{"key":"10.1016\/j.cjca.2014.08.022_bib20","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1161\/ATVBAHA.107.155960","article-title":"Assessing identity, phenotype, and fate of endothelial progenitor cells","volume":"28","author":"Hirschi","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cjca.2014.08.022_bib21","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/eci.12009","article-title":"The diverse identity of angiogenic monocytes","volume":"43","author":"Favre","year":"2013","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.cjca.2014.08.022_bib22","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1182\/blood-2005-04-1509","article-title":"Unresolved questions, changing definitions, and novel paradigms for defining endothelial progenitor cells","volume":"106","author":"Ingram","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.cjca.2014.08.022_bib23","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/stem.1280","article-title":"Late outgrowth endothelial cells resemble mature endothelial cells and are not derived from bone marrow","volume":"31","author":"Tura","year":"2013","journal-title":"Stem Cells"},{"key":"10.1016\/j.cjca.2014.08.022_bib24","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1161\/ATVBAHA.111.244210","article-title":"Flow cytometric identification and functional characterization of immature and mature circulating endothelial cells","volume":"32","author":"Mund","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"suppl 1","key":"10.1016\/j.cjca.2014.08.022_bib25","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1538-7836.2009.03407.x","article-title":"Defining human endothelial progenitor cells","volume":"7","author":"Yoder","year":"2009","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.cjca.2014.08.022_bib26","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1161\/01.ATV.0000114236.77009.06","article-title":"Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis","volume":"24","author":"Hur","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cjca.2014.08.022_bib27","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1378\/chest.10-2348","article-title":"Bone marrow-derived stem cells and respiratory disease","volume":"140","author":"Jones","year":"2011","journal-title":"Chest"},{"key":"10.1016\/j.cjca.2014.08.022_bib28","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1755-8794-3-18","article-title":"Molecular analysis of endothelial progenitor cell (EPC) subtypes reveals two distinct cell populations with different identities","volume":"3","author":"Medina","year":"2010","journal-title":"BMC Med Genomics"},{"key":"10.1016\/j.cjca.2014.08.022_bib29","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1161\/CIRCULATIONAHA.104.503433","article-title":"Synergistic neovascularization by mixed transplantation of early endothelial progenitor cells and late outgrowth endothelial cells: the role of angiogenic cytokines and matrix metalloproteinases","volume":"112","author":"Yoon","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2014.08.022_bib30","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1182\/blood-2004-04-1396","article-title":"Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood","volume":"104","author":"Ingram","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.cjca.2014.08.022_bib31","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1182\/blood-2006-08-043471","article-title":"Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem\/progenitor cell principals","volume":"109","author":"Yoder","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.cjca.2014.08.022_bib32","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1002\/cphy.c120034","article-title":"Targeted delivery of genes to endothelial cells and cell- and gene-based therapy in pulmonary vascular diseases","volume":"3","author":"Suen","year":"2013","journal-title":"Compr Physiol"},{"key":"10.1016\/j.cjca.2014.08.022_bib33","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1161\/01.RES.0000157672.70560.7b","article-title":"Rescue of monocrotaline-induced pulmonary arterial hypertension using bone marrow-derived endothelial-like progenitor cells: efficacy of combined cell and eNOS gene therapy in established disease","volume":"96","author":"Zhao","year":"2005","journal-title":"Circ Res"},{"key":"10.1016\/j.cjca.2014.08.022_bib34","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1165\/rcmb.2009-0152OC","article-title":"Innate immunity in the therapeutic actions of endothelial progenitor cells in pulmonary hypertension","volume":"43","author":"Ormiston","year":"2010","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.cjca.2014.08.022_bib35","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1755-1536-1-4","article-title":"Role of paracrine factors in stem and progenitor cell-mediated cardiac repair and tissue fibrosis","volume":"1","author":"Burchfield","year":"2008","journal-title":"Fibrogenesis Tissue Repair"},{"key":"10.1016\/j.cjca.2014.08.022_bib36","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1084\/jem.20070166","article-title":"Role of host tissues for sustained humoral effects after endothelial progenitor cell transplantation into the ischemic heart","volume":"204","author":"Cho","year":"2007","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.cjca.2014.08.022_bib37","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.yjmcc.2005.07.003","article-title":"Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells","volume":"39","author":"Urbich","year":"2005","journal-title":"J\u00a0Mol Cell Cardiol"},{"key":"10.1016\/j.cjca.2014.08.022_bib38","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1161\/CIRCULATIONAHA.114.009124","article-title":"Existence, functional impairment, and lung repair potential of endothelial colony-forming cells in oxygen-induced arrested alveolar growth","volume":"129","author":"Alphonse","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2014.08.022_bib39","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1016\/j.jacc.2006.12.037","article-title":"Transplantation of autologous endothelial progenitor cells may be beneficial in patients with idiopathic pulmonary arterial hypertension: a pilot randomized controlled trial","volume":"49","author":"Wang","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2014.08.022_bib40","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/j.1399-3046.2007.00863.x","article-title":"Safety and efficacy of autologous endothelial progenitor cells transplantation in children with idiopathic pulmonary arterial hypertension: open-label pilot study","volume":"12","author":"Zhu","year":"2008","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.cjca.2014.08.022_bib41","doi-asserted-by":"crossref","first-page":"L12","DOI":"10.1152\/ajplung.00215.2010","article-title":"Treatment of pulmonary arterial hypertension with circulating angiogenic cells","volume":"301","author":"Mirsky","year":"2011","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.cjca.2014.08.022_bib42","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1161\/hc4201.097838","article-title":"Cell-based gene transfer of vascular endothelial growth factor attenuates monocrotaline-induced pulmonary hypertension","volume":"104","author":"Campbell","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2014.08.022_bib43","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1165\/rcmb.2005-0115OC","article-title":"Microvascular regeneration in established pulmonary hypertension by angiogenic gene transfer","volume":"35","author":"Zhao","year":"2006","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.cjca.2014.08.022_bib44","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1161\/01.RES.0000070587.79937.F0","article-title":"Protective role of angiopoietin-1 in experimental pulmonary hypertension","volume":"92","author":"Zhao","year":"2003","journal-title":"Circ Res"},{"key":"10.1016\/j.cjca.2014.08.022_bib45","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1161\/01.CIR.0000079161.56080.22","article-title":"Hybrid cell-gene therapy for pulmonary hypertension based on phagocytosing action of endothelial progenitor cells","volume":"108","author":"Nagaya","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2014.08.022_bib46","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.athoracsur.2007.03.067","article-title":"Effect of prepro-calcitonin gene-related peptide-expressing endothelial progenitor cells on pulmonary hypertension","volume":"84","author":"Zhao","year":"2007","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.cjca.2014.08.022_bib47","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1165\/ajrcmb.21.5.3640","article-title":"Cell-based gene transfer to the pulmonary vasculature: endothelial nitric oxide synthase overexpression inhibits monocrotaline-induced pulmonary hypertension","volume":"21","author":"Campbell","year":"1999","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.cjca.2014.08.022_bib48","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/hr.2012.217","article-title":"Therapeutic effect of eNOS-transfected endothelial progenitor cells on hemodynamic pulmonary arterial hypertension","volume":"36","author":"Wei","year":"2013","journal-title":"Hypertens Res"},{"key":"10.1016\/j.cjca.2014.08.022_bib49","doi-asserted-by":"crossref","first-page":"e47559","DOI":"10.1371\/journal.pone.0047559","article-title":"Safety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review and meta-analysis of clinical trials","volume":"7","author":"Lalu","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.cjca.2014.08.022_bib50","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/14653240600855905","article-title":"Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement","volume":"8","author":"Dominici","year":"2006","journal-title":"Cytotherapy"},{"key":"10.1016\/j.cjca.2014.08.022_bib51","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1126\/science.284.5411.143","article-title":"Multilineage potential of adult human mesenchymal stem cells","volume":"284","author":"Pittenger","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.cjca.2014.08.022_bib52","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1634\/stemcells.2007-1122","article-title":"In search of the in\u00a0vivo identity of mesenchymal stem cells","volume":"26","author":"da Silva Meirelles","year":"2008","journal-title":"Stem Cells"},{"key":"10.1016\/j.cjca.2014.08.022_bib53","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1172\/JCI29713","article-title":"Evidence for tissue-resident mesenchymal stem cells in human adult lung from studies of transplanted allografts","volume":"117","author":"Lama","year":"2007","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.cjca.2014.08.022_bib54","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1242\/jcs.02932","article-title":"Mesenchymal stem cells reside in virtually all post-natal organs and tissues","volume":"119","author":"da Silva Meirelles","year":"2006","journal-title":"J\u00a0Cell Sci"},{"key":"10.1016\/j.cjca.2014.08.022_bib55","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.stem.2012.02.005","article-title":"Harnessing the mesenchymal stem cell secretome for the treatment of cardiovascular disease","volume":"10","author":"Ranganath","year":"2012","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.cjca.2014.08.022_bib56","doi-asserted-by":"crossref","first-page":"H1120","DOI":"10.1152\/ajpheart.00173.2006","article-title":"Intratracheal mesenchymal stem cell administration attenuates monocrotaline-induced pulmonary hypertension and endothelial dysfunction","volume":"292","author":"Baber","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.cjca.2014.08.022_bib57","doi-asserted-by":"crossref","first-page":"911","DOI":"10.3727\/096368908786576444","article-title":"Assessment of a nuclear affinity labeling method for tracking implanted mesenchymal stem cells","volume":"17","author":"Leiker","year":"2008","journal-title":"Cell Transplant"},{"key":"10.1016\/j.cjca.2014.08.022_bib58","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.jcyt.2013.02.010","article-title":"Immunological characterization of multipotent mesenchymal stromal cells\u2013The International Society for Cellular Therapy (ISCT) working proposal","volume":"15","author":"Krampera","year":"2013","journal-title":"Cytotherapy"},{"key":"10.1016\/j.cjca.2014.08.022_bib59","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.stem.2007.11.014","article-title":"Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide","volume":"2","author":"Ren","year":"2008","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.cjca.2014.08.022_bib60","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1476-9255-2-8","article-title":"Mesenchymal stem cells avoid allogeneic rejection","volume":"2","author":"Ryan","year":"2005","journal-title":"J\u00a0Inflamm (Lond)"},{"key":"10.1016\/j.cjca.2014.08.022_bib61","first-page":"I181","article-title":"Implantation of mesenchymal stem cells overexpressing endothelial nitric oxide synthase improves right ventricular impairments caused by pulmonary hypertension","volume":"114","author":"Kanki-Horimoto","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2014.08.022_bib62","doi-asserted-by":"crossref","first-page":"H1606","DOI":"10.1152\/ajpheart.00590.2009","article-title":"Allogenic stem cell therapy improves right ventricular function by improving lung pathology in rats with pulmonary hypertension","volume":"297","author":"Umar","year":"2009","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.cjca.2014.08.022_bib63","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/MAJ.0b013e31822dc5d3","article-title":"Implantation of mesenchymal stem cells improves right ventricular impairments caused by experimental pulmonary hypertension","volume":"343","author":"Luan","year":"2012","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.cjca.2014.08.022_bib64","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1161\/CIRCULATIONAHA.112.114173","article-title":"Exosomes mediate the cytoprotective action of mesenchymal stromal cells on hypoxia-induced pulmonary hypertension","volume":"126","author":"Lee","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2014.08.022_bib65","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/ncb1596","article-title":"Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells","volume":"9","author":"Valadi","year":"2007","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.cjca.2014.08.022_bib66","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.bbagen.2012.03.017","article-title":"Exosomes: current knowledge of their composition, biological functions, and diagnostic and therapeutic potentials","volume":"1820","author":"Vlassov","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.cjca.2014.08.022_bib67","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s00395-009-0065-8","article-title":"Mesenchymal stem cell-based prostacyclin synthase gene therapy for pulmonary hypertension rats","volume":"105","author":"Takemiya","year":"2010","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.cjca.2014.08.022_bib68","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/stem.548","article-title":"Mesenchymal stromal cells expressing heme oxygenase-1 reverse pulmonary hypertension","volume":"29","author":"Liang","year":"2011","journal-title":"Stem Cells"},{"key":"10.1016\/j.cjca.2014.08.022_bib69","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/35099560","article-title":"Recognition of double-stranded RNA and activation of NF-kappaB by toll-like receptor 3","volume":"413","author":"Alexopoulou","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.cjca.2014.08.022_bib70","doi-asserted-by":"crossref","first-page":"e45590","DOI":"10.1371\/journal.pone.0045590","article-title":"Mesenchymal stem cell 1 (MSC1)-based therapy attenuates tumor growth whereas MSC2-treatment promotes tumor growth and metastasis","volume":"7","author":"Waterman","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.cjca.2014.08.022_bib71","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/stem.1543","article-title":"The toll-like receptor 3 ligand, poly(I: C), improves immunosuppressive function and therapeutic effect of mesenchymal stem cells on sepsis via inhibiting MiR-143","volume":"32","author":"Zhao","year":"2014","journal-title":"Stem Cells"},{"key":"10.1016\/j.cjca.2014.08.022_bib72","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1634\/stemcells.2007-1104","article-title":"Hypoxic preconditioning results in increased motility and improved therapeutic potential of human mesenchymal stem cells","volume":"26","author":"Rosova","year":"2008","journal-title":"Stem Cells"},{"key":"10.1016\/j.cjca.2014.08.022_bib73","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors","volume":"126","author":"Takahashi","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.cjca.2014.08.022_bib74","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nature05934","article-title":"Generation of germline-competent induced pluripotent stem cells","volume":"448","author":"Okita","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.cjca.2014.08.022_bib75","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1089\/scd.2010.0426","article-title":"Functional characterization and expression profiling of human induced pluripotent stem cell- and embryonic stem cell-derived endothelial cells","volume":"20","author":"Li","year":"2011","journal-title":"Stem Cells Dev"},{"key":"10.1016\/j.cjca.2014.08.022_bib76","doi-asserted-by":"crossref","first-page":"e57876","DOI":"10.1371\/journal.pone.0057876","article-title":"Attenuation of hind-limb ischemia in mice with endothelial-like cells derived from different sources of human stem cells","volume":"8","author":"Lai","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.cjca.2014.08.022_bib77","doi-asserted-by":"crossref","first-page":"13793","DOI":"10.1073\/pnas.1205526109","article-title":"Direct reprogramming of fibroblasts into endothelial cells capable of angiogenesis and reendothelialization in tissue-engineered vessels","volume":"109","author":"Margariti","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cjca.2014.08.022_bib78","doi-asserted-by":"crossref","first-page":"153","DOI":"10.4103\/2045-8932.109963","article-title":"Combining induced pluripotent stem cell with next generation sequencing technology to gain new insights into pathobiology and treatment of pulmonary arterial hypertension","volume":"3","author":"Rabinovitch","year":"2013","journal-title":"Pulm Circ"},{"key":"10.1016\/j.cjca.2014.08.022_bib79","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.stemcr.2013.06.007","article-title":"Functional vascular endothelium derived from human induced pluripotent stem cells","volume":"1","author":"Adams","year":"2013","journal-title":"Stem Cell Reports"},{"key":"10.1016\/j.cjca.2014.08.022_bib80","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1161\/CIRCULATIONAHA.114.008777","article-title":"Proteomic analysis implicates translationally controlled tumor protein as a novel mediator of occlusive vascular remodeling in pulmonary arterial hypertension","volume":"129","author":"Lavoie","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2014.08.022_bib81","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/cdd.2010.126","article-title":"Caspase-3-dependent export of TCTP: a novel pathway for antiapoptotic intercellular communication","volume":"18","author":"Sirois","year":"2011","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.cjca.2014.08.022_bib82","unstructured":"U.S. Department of Health and Human Services. Organ Procurement and Transplantation Network. Available at: http:\/\/optn.transplant.hrsa.gov. Accessed August 1,\u00a02014."},{"key":"10.1016\/j.cjca.2014.08.022_bib83","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1513\/pats.200808-077GO","article-title":"Medical complications of lung transplantation","volume":"6","author":"Lyu","year":"2009","journal-title":"Proc Am Thorac Soc"},{"key":"10.1016\/j.cjca.2014.08.022_bib84","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1111\/resp.12102","article-title":"Can stem cells be used to generate new lungs? Ex\u00a0vivo lung bioengineering with decellularized whole lung scaffolds","volume":"18","author":"Wagner","year":"2013","journal-title":"Respirology"},{"key":"10.1016\/j.cjca.2014.08.022_bib85","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/nm.2193","article-title":"Regeneration and orthotopic transplantation of a bioartificial lung","volume":"16","author":"Ott","year":"2010","journal-title":"Nat Med"},{"key":"10.1016\/j.cjca.2014.08.022_bib86","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1016\/S0140-6736(08)61598-6","article-title":"Clinical transplantation of a tissue-engineered airway","volume":"372","author":"Macchiarini","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2014.08.022_bib87","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0140-6736(13)62033-4","article-title":"The first tissue-engineered airway transplantation: 5-year follow-up results","volume":"383","author":"Gonfiotti","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2014.08.022_bib88","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1146\/annurev-bioeng-071910-124743","article-title":"Whole-organ tissue engineering: decellularization and recellularization of three-dimensional matrix scaffolds","volume":"13","author":"Badylak","year":"2011","journal-title":"Annu Rev Biomed Eng"},{"key":"10.1016\/j.cjca.2014.08.022_bib89","first-page":"L3","article-title":"Extracellular matrix biology in the lung","volume":"270","author":"Dunsmore","year":"1996","journal-title":"Am J Physiol"},{"key":"10.1016\/j.cjca.2014.08.022_bib90","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/ten.tea.2011.0301","article-title":"Initial binding and recellularization of decellularized mouse lung scaffolds with bone marrow-derived mesenchymal stromal cells","volume":"18","author":"Daly","year":"2012","journal-title":"Tissue Eng Part A"},{"key":"10.1016\/j.cjca.2014.08.022_bib91","doi-asserted-by":"crossref","first-page":"4950","DOI":"10.1172\/JCI68793","article-title":"Human iPS cell-derived alveolar epithelium repopulates lung extracellular matrix","volume":"123","author":"Ghaedi","year":"2013","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.cjca.2014.08.022_bib92","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1126\/science.1189345","article-title":"Tissue-engineered lungs for in\u00a0vivo implantation","volume":"329","author":"Petersen","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.cjca.2014.08.022_bib93","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1089\/ten.tea.2013.0438","article-title":"Hypertensive rat lungs retain hallmarks of vascular disease upon decellularization but support the growth of mesenchymal stem cells","volume":"20","author":"Scarritt","year":"2014","journal-title":"Tissue Eng Part A"},{"key":"10.1016\/j.cjca.2014.08.022_bib94","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.athoracsur.2011.05.018","article-title":"Enhanced in\u00a0vivo function of bioartificial lungs in rats","volume":"92","author":"Song","year":"2011","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.cjca.2014.08.022_bib95","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.healun.2013.10.030","article-title":"Perfusion decellularization of human and porcine lungs: bringing the matrix to clinical scale","volume":"33","author":"Gilpin","year":"2014","journal-title":"J\u00a0Heart Lung Transplant"}],"container-title":["Canadian Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X14012902?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X14012902?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,23]],"date-time":"2020-08-23T19:18:36Z","timestamp":1598210316000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0828282X14012902"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":95,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S0828282X14012902"],"URL":"https:\/\/doi.org\/10.1016\/j.cjca.2014.08.022","relation":{},"ISSN":["0828-282X"],"issn-type":[{"value":"0828-282X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Regenerative Cell and Tissue-based Therapies for Pulmonary Arterial Hypertension","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjca.2014.08.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}